Academic literature on the topic 'CNS drugs'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'CNS drugs.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "CNS drugs"
Generali, Joyce A. "CNS and Psychiatric Drugs." Hospital Pharmacy 37, no. 8 (August 2002): 888–94. http://dx.doi.org/10.1177/001857870203700802.
Full textMarsden, Charles A., and S. Clare Stanford. "CNS Drugs III: Psychotherapeutics." Expert Opinion on Investigational Drugs 9, no. 8 (August 2000): 1923–29. http://dx.doi.org/10.1517/13543784.9.8.1923.
Full textVastag, B. "More Children on CNS Drugs." JAMA: The Journal of the American Medical Association 287, no. 15 (April 17, 2002): 1930—a—1930. http://dx.doi.org/10.1001/jama.287.15.1930-a.
Full textVastag, Brian. "More Children on CNS Drugs." JAMA 287, no. 15 (April 17, 2002): 1930. http://dx.doi.org/10.1001/jama.287.15.1930-jha20004-2-1.
Full textSchou, Magnus, and Katarina Varnäs. "PET microdosing of CNS drugs." Clinical and Translational Imaging 5, no. 3 (March 23, 2017): 291–98. http://dx.doi.org/10.1007/s40336-017-0226-y.
Full textTobinick, Edward Lewis. "Perispinal Delivery of CNS Drugs." CNS Drugs 30, no. 6 (April 27, 2016): 469–80. http://dx.doi.org/10.1007/s40263-016-0339-2.
Full text&NA;. "Elderly less tolerant of CNS drugs." Reactions Weekly &NA;, no. 501 (May 1994): 3. http://dx.doi.org/10.2165/00128415-199405010-00005.
Full textGhose, Karabi. "Prescribing CNS Drugs for Elderly Patients." Drugs & Aging 4, no. 4 (April 1994): 275–84. http://dx.doi.org/10.2165/00002512-199404040-00001.
Full textBOSCHERT, SHERRY. "CNS Drugs And Cognitive Decline Tied." Family Practice News 38, no. 4 (February 2008): 34. http://dx.doi.org/10.1016/s0300-7073(08)70241-x.
Full textPreskorn, Sheldon H. "CNS Drug Development: Part I: The Early Period of CNS Drugs." Journal of Psychiatric Practice 16, no. 5 (September 2010): 334–39. http://dx.doi.org/10.1097/01.pra.0000388628.44405.c0.
Full textDissertations / Theses on the topic "CNS drugs"
Kyles, Andrew Edward. "Evaluation of the spinal and supraspinal roles of antinociceptive drugs in sheep." Thesis, University of Bristol, 1992. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.389998.
Full textRahman, Shazia. "Use of (2S)-pyroglutamic acid for the synthesis of glutamate agonists and antagonists and 1-#beta#-methylcarbapenams." Thesis, University of Sussex, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.264581.
Full textSekhar, Gayathri Nair. "The transport of CNS-active cationic drugs across the blood-brain barrier." Thesis, King's College London (University of London), 2016. https://kclpure.kcl.ac.uk/portal/en/theses/the-transport-of-cnsactive-cationic-drugs-across-the-bloodbrain-barrier(41ff27df-17ce-4edc-82fe-c4169edf801c).html.
Full textLloyd, Edward John, and mikewood@deakin edu au. "A common structural basis for central nervous system drug design." Deakin University. School of Biological Sciences, 1986. http://tux.lib.deakin.edu.au./adt-VDU/public/adt-VDU20050902.115505.
Full textBerggård, Cecilia. "Transcription Factor AP-2 in Relation to Personality and Antidepressant Drugs." Doctoral thesis, Uppsala University, Department of Neuroscience, 2004. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4638.
Full textThe CNS monoaminergic systems are considered as the head engine regulating neuropsychiatric functions and personality. Transcription factor AP-2 is known to be essential for the development of the brainstem including the monoaminergic nuclei, and has the ability to regulate many genes in the monoaminergic systems. The ability of transcription factors to regulate specific gene expression, has lately made them hot candidates as drug targets. In this thesis, results indicating a role of AP-2 in the molecular effects of the antidepressant drugs citalopram and phenelzine, are presented.
A polymorphism in the second intron of the gene encoding AP-2ß has previously been associated with anxiety-related personality traits as estimated by the Karolinska Scales of Personality (KSP). In this thesis, results confirming this association, gained by using a larger material and several different personality scales, are presented. Furthermore, data is presented showing an association between the activity of platelet monoamine oxidase, a trait-dependent marker for personality, and the genotype of the AP-2ß intron 2 polymorphism.
The functional importance of the AP-2ß intron 2 polymorphism has not yet been elucidated. Included in this thesis are results showing that the AP-2ß intron 2 polymorphism is not in linkage disequilibrium with the only other described polymorphism in the AP-2ß gene, i.e. in the AP-2ß promoter (-67 G/A). Introns have in several studies been shown to include binding sites for regulatory proteins, and thus, to be important in transcriptional regulation. Results are presented demonstrating that one human brain nuclear protein binds only to the long variant of the AP-2ß intron 2 polymorphism. If this protein is involved in the regulation of the AP-2ß gene, it would affect the expression levels of the AP-2ß protein.
In general, this thesis further establishes the role of transcription factor AP-2 as a regulatory factor of importance for personality and monoaminergic functions.
Patel, Sulay H. "Effects of HIV-1 Tat and drugs of abuse on antiretroviral penetration inside different CNS cell types." VCU Scholars Compass, 2018. https://scholarscompass.vcu.edu/etd/5685.
Full textGarcia-Mijares, Miriam. "Efeito da administração aguda e repetida de fencanfamina sobre o valor reforçado do estímulo." Universidade de São Paulo, 2000. http://www.teses.usp.br/teses/disponiveis/47/47135/tde-14092006-114120/.
Full textFencanfamina (FCF) is an indirect dopaminergic agonist with neural and behavioral effects similar to those observed for other stimulant drugs such as the amphetamine or cocaine (COC). The aim of the present investigation was to evaluate the effect of acute and repeated administration of FCF on the reinforcing value (Re) taken as a motivational index. The Herrnstein hyperbole equation (1970) was used to evaluate this motivacional effect. The effects of FCF on response rate and motor capacity (k) where also observed. Three experiments were conducted. In all of them the effect of FCF was tested on rats trained on seven VI multiple schedule. In Experiments 1 and 2 (E1 and E2, respectively) three acute doses of FCF (0.88 mg/kg, 1.75 mg/kg and 3.5 mg/kg) were administered (i.p.) The reinforcer was water (E1) or sacarose (E2). In both experiments, the effect of the drug on the parameters studied was similar: the three doses of FCF increased the response rate, decreased Re and had no effect on k. In Experiment 3, six injections of vehicle (VEI Group) or 1.75 mg/kg of FCF (DROGA Group) were intermittently administered (i.p.) in order to promote sensitization. Seven days after drug withdrawal a single dose of 0.88 mg/kg of FCF was administered to animals in both groups and the effect on response rate, k and Re was measured. Results showed that repeated administration of FCF did not change the effect of this drug on the parameters investigated. These results are consistent with the evidence showing that FCF has behavioral effects similar to those reported for other stimulants and support the interpretation that increases in response rate are primarily related to changes in reinforcing value. Thus they probably reflect a motivational effect of the drug. Moreover, the results support the hypotheses that associate the dopaminergic system to the process of reinforcement. It is speculate that the failure to obtain sensitization after repeated administration of FCF could be related to dosage or number of injections.
Mercolini, Laura <1979>. "Development of original analytical methods for the therapeutic drug monitoring of CNS druges: Antipsychotics, Antidepressants and Anxiolytics-hypnotics." Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2010. http://amsdottorato.unibo.it/2713/.
Full textJain, Anjana. "Delivery of Cdc42, Rac1, and Brain-derived Neurotrophic Factor to Promote Axonal Outgrowth After Spinal Cord Injury." Diss., Georgia Institute of Technology, 2007. http://hdl.handle.net/1853/16210.
Full textFidanboylu, Mehmet. "Blood-CNS transport mechanisms in pathophysiology and drug delivery." Thesis, King's College London (University of London), 2013. https://kclpure.kcl.ac.uk/portal/en/theses/bloodcns-transport-mechanisms-in-pathophysiology-and-drug-delivery(2081d984-07fe-41aa-9f5b-54d1f33be9f2).html.
Full textBooks on the topic "CNS drugs"
International Bioanalytical Forum (6th 1985 University of Surrey). Bioactive analytes: Including CNS drugs, peptides, and enantiomers. New York: Plenum Press, 1986.
Find full textReid, Eric, Bryan Scales, and Ian D. Wilson, eds. BIOACTIVE ANALYTES, Including CNS Drugs, Peptides, and Enantiomers. Boston, MA: Springer US, 1986. http://dx.doi.org/10.1007/978-1-4757-1892-8.
Full textMcArthur, Robert A., and Franco Borsini. Animal and translational models for CNS drug discovery. Amsterdam: Elsevier/Academic Press, 2008.
Find full textKalali, Amir, Joseph Kwentus, Sheldon Preskorn, and Stephen M. Stahl, eds. Essential CNS Drug Development. Cambridge: Cambridge University Press, 2012. http://dx.doi.org/10.1017/cbo9780511977640.
Full textEssential CNS drug development. Cambridge: Cambridge University Press, 2012.
Find full textSchreiber, Rudy, ed. Modern CNS Drug Discovery. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-62351-7.
Full textBorsook, David, Lino R. Beccera, Edward Bullmore, and Richard J. Hargreaves, eds. Imaging in CNS Drug Discovery and Development. New York, NY: Springer New York, 2009. http://dx.doi.org/10.1007/978-1-4419-0134-7.
Full textAtta-ur-Rahman and M. Iqbal Choudhary, eds. Frontiers in CNS Drug Discovery Volume 3. UAE: Bentham Science Publishers Ltd., 2017. http://dx.doi.org/10.2174/97816810844351170301.
Full textCes drôles de médicaments. Paris: Delagrange, 1990.
Find full textConcise clinical pharmacology: CNS therapeutics. New York: McGraw-Hill, Medical Pub. Division, 2007.
Find full textBook chapters on the topic "CNS drugs"
Lowe, John A. "CNS Drugs." In Drug Discovery, 245–86. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2013. http://dx.doi.org/10.1002/9781118354483.ch7.
Full textBuccafusco, Jerry J., and Moussa B. H. Youdim. "Drugs with multiple CNS targets." In Cognitive Enhancing Drugs, 179–98. Basel: Birkhäuser Basel, 2004. http://dx.doi.org/10.1007/978-3-0348-7867-8_11.
Full textBhandari, Prasan. "CNS stimulants/drugs of abuse." In Pharmacology Mind Maps for Medical Students and Allied Health Professionals, 274–80. Boca Raton, FL : CRC Press/Taylor & Francis, 2020.: CRC Press, 2019. http://dx.doi.org/10.1201/9780429023859-30.
Full textRiedel, Wim. "The Special Challenges of Developing CNS Drugs." In Modern CNS Drug Discovery, 231–34. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-62351-7_15.
Full textWenger, Galen R. "CNS Stimulants and Athletic Performance." In Drugs, Athletes, and Physical Performance, 217–34. Boston, MA: Springer US, 1988. http://dx.doi.org/10.1007/978-1-4684-5499-4_14.
Full textRankovic, Zoran. "Designing CNS Drugs for Optimal Brain Exposure." In Blood-Brain Barrier in Drug Discovery, 385–424. Hoboken, NJ: John Wiley & Sons, Inc, 2015. http://dx.doi.org/10.1002/9781118788523.ch18.
Full textNemes, András. "Monoterpenoid Indole Alkaloids, CNS and Anticancer Drugs." In Analogue-Based Drug Discovery II, 189–215. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA, 2010. http://dx.doi.org/10.1002/9783527630035.ch8.
Full textCaddy, B., and W. M. L. Chow. "Novel Capillary Gas-Chromatographic Phases Applicable to Drugs." In BIOACTIVE ANALYTES, Including CNS Drugs, Peptides, and Enantiomers, 221–34. Boston, MA: Springer US, 1986. http://dx.doi.org/10.1007/978-1-4757-1892-8_18.
Full textFeitsma, Karla G., Ben F. H. Drenth, Kor H. Kooi, Jan Bosman, and Rokus A. de Zeeuw. "Attempts to Obtain Separations of Chiral Anticholinergic Drugs." In BIOACTIVE ANALYTES, Including CNS Drugs, Peptides, and Enantiomers, 259–69. Boston, MA: Springer US, 1986. http://dx.doi.org/10.1007/978-1-4757-1892-8_21.
Full textVerster, Joris C. "Effects of CNS-Drugs and Alcohol on Driving Ability." In Sleepiness and Human Impact Assessment, 113–19. Milano: Springer Milan, 2014. http://dx.doi.org/10.1007/978-88-470-5388-5_10.
Full textConference papers on the topic "CNS drugs"
Batchu, Jayanth V. N., and Abasifreke U. Ebong. "Photovoltaic therapy: Conceptual nanoscopic photovoltaic device for transporting chemotherapeutic drugs." In 2013 10th International Conference on High Capacity Optical Networks and Enabling Technologies (HONET-CNS). IEEE, 2013. http://dx.doi.org/10.1109/honet.2013.6729760.
Full textKim, Jung Hwan, Garrett W. Astary, Thomas H. Mareci, and Malisa Sarntinoranont. "A Computational Model of Direct Infusion Into the Rat Brain: Corpus Callosum and Hippocampus." In ASME 2009 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2009. http://dx.doi.org/10.1115/sbc2009-205945.
Full textLueshen, Eric, Indu Venugopal, and Andreas Linninger. "Intrathecal Magnetic Drug Targeting: A New Approach to Treating Diseases of the Central Nervous System." In ASME 2013 2nd Global Congress on NanoEngineering for Medicine and Biology. American Society of Mechanical Engineers, 2013. http://dx.doi.org/10.1115/nemb2013-93117.
Full textLabrecque, S., J. P. Sylvestre, S. Marcet, F. Mangiarini, M. Verhaegen, P. De Koninck, and S. Blais-Ouellette. "Hyperspectral imaging to monitor simultaneously multiple protein subtypes and live track their spatial dynamics: a new platform to screen drugs for CNS diseases." In SPIE BiOS, edited by Daniel L. Farkas, Dan V. Nicolau, and Robert C. Leif. SPIE, 2015. http://dx.doi.org/10.1117/12.2079882.
Full textBhosle, Abhinav, Pratibha Singhal, Vibhor Pardasani, Prajay Lunia, Kanchan Ajbani, Dipak Dhangar, and Suhas Tiple. "Pyrosequencing(PSQ) in early diagnosis of CNS tuberculosis and determining drug resistance." In ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa4590.
Full textIliescu, Ciprian, Bangtao Chen, Jiashen Wei, and Zhilian Yue. "Transdermal drug delivery: Microfabrication insights." In 2009 International Semiconductor Conference (CAS 2009). IEEE, 2009. http://dx.doi.org/10.1109/smicnd.2009.5336568.
Full textSalvador, Ellaine, Almuth F. Kessler, Julia Hörmann, Malgorzata Burek, Catherine T. Brami, Tali V. Sela, Moshe Giladi, et al. "Abstract 6251: Blood brain barrier opening by TTFields: a future CNS drug delivery strategy." In Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-6251.
Full textDoutremepuich, C., O. de Sèze, T. Castrioto, F. Peirera, F. Doutremepuich, and F. Toulemonde. "TREATMENT OF EXPERIMENTAL VENOUS STASIS MODEL IN RATS BY HEPARIN AND A VERY LOW MOLECULAR WEIGHT HEPARIN FRAGMENT. RELATIONSHIP TO PLASMATIC HEPARIN ACTIVITY." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644850.
Full textYuvenda, Dori, Bambang Sudarmanta, and Arif Wahjudi. "Optimization of CNG injection duration on combustions and emissions characteristics on CNG-CPO biodiesel dual fuel engine with load variations." In THE 4TH BIOMEDICAL ENGINEERING’S RECENT PROGRESS IN BIOMATERIALS, DRUGS DEVELOPMENT, HEALTH, AND MEDICAL DEVICES: Proceedings of the International Symposium of Biomedical Engineering (ISBE) 2019. AIP Publishing, 2019. http://dx.doi.org/10.1063/1.5138281.
Full textKleps, I., A. Bragaru, T. Ignat, M. Miu, M. Simion, F. Craciunoiu, M. Danila, et al. "Nanostructured microcarriers based on silicon for drug delivery." In 2009 International Semiconductor Conference (CAS 2009). IEEE, 2009. http://dx.doi.org/10.1109/smicnd.2009.5336586.
Full textReports on the topic "CNS drugs"
Mery, Laura, Matthew Wayner, John McQuade, and Erica Anderson. Characterization of the Effects of Fatigue on the Central Nervous System (CNS) and Drug Therapies. Fort Belvoir, VA: Defense Technical Information Center, November 2007. http://dx.doi.org/10.21236/ada489794.
Full textCarroll, David. Targeted CNx Nanowire-Drug Complexes for Enhanced Chemotherapeutic Efficacy. Fort Belvoir, VA: Defense Technical Information Center, September 2009. http://dx.doi.org/10.21236/ada534933.
Full textSalaymeh, S. R. Scrap Cans Assayed in 55-Gallon Drums by Adapted Q2 Technique. Office of Scientific and Technical Information (OSTI), July 2001. http://dx.doi.org/10.2172/783815.
Full textPerceptions of community pharmacists, patent and proprietary medicine vendors, and their clients regarding quality of family planning services: The IntegratE Project. Population Council, 2021. http://dx.doi.org/10.31899/rh17.1016.
Full text